FDA
label_change
· 2012-07-19
FDA Approved: CLONAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved a supplemental application for clonazepam to update the labeling of Teva's clonazepam product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CLONAZEPAM (CLONAZEPAM)